“Biopharma manufacturing is all set to get a boost, with an outlay of INR 10,000 crores proposed in the budget 2026. The global Biopharmaceutical market is expected to experience significant growth and projected to rise from approximately 450 billion USD to 720 billion in 2023–2026 to over 1 trillion in early 2030s. Biotech drugmakers were expecting a positive boost from the budget 2026, and the announcement with due implementation should provide the much-needed push to the sector given its robust growth potential.”
- Advertisement -
